Reducing hyperglucagonaemia in type 2 diabetes using low-dose glibenclamide: Results of the LEGEND-A pilot study.

Spiliotis II., Chalk R., Gough S., Rorsman P.

DOI

10.1111/dom.14740

Type

Journal article

Journal

Diabetes Obes Metab

Publication Date

08/2022

Volume

24

Pages

1671 - 1675

Keywords

antidiabetic drug, clinical trial, drug mechanism, experimental pharmacology, glucagon, type 2 diabetes, Blood Glucose, Diabetes Mellitus, Type 2, Glucagon, Glyburide, Humans, Hypoglycemic Agents, Insulin, Pilot Projects

Permalink Original publication